BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 14559776)

  • 21. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
    Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
    PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orchestra for assembly and fate of polyubiquitin chains.
    Kuhlbrodt K; Mouysset J; Hoppe T
    Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.
    Ricchelli F; Fusi P; Tortora P; Valtorta M; Riva M; Tognon G; Chieregato K; Bolognin S; Zatta P
    Int J Biochem Cell Biol; 2007; 39(5):966-77. PubMed ID: 17300980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
    Matsumoto M
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains.
    Wilkinson CR; Seeger M; Hartmann-Petersen R; Stone M; Wallace M; Semple C; Gordon C
    Nat Cell Biol; 2001 Oct; 3(10):939-43. PubMed ID: 11584278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains.
    Ko HS; Uehara T; Tsuruma K; Nomura Y
    FEBS Lett; 2004 May; 566(1-3):110-4. PubMed ID: 15147878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation.
    Seibenhener ML; Babu JR; Geetha T; Wong HC; Krishna NR; Wooten MW
    Mol Cell Biol; 2004 Sep; 24(18):8055-68. PubMed ID: 15340068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor MD; Wilkinson KD; Warren ST
    J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEDD8: a new ataxin-3 interactor.
    Ferro A; Carvalho AL; Teixeira-Castro A; Almeida C; Tomé RJ; Cortes L; Rodrigues AJ; Logarinho E; Sequeiros J; Macedo-Ribeiro S; Maciel P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1619-27. PubMed ID: 17935801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
    Todi SV; Laco MN; Winborn BJ; Travis SM; Wen HM; Paulson HL
    J Biol Chem; 2007 Oct; 282(40):29348-58. PubMed ID: 17693639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
    Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
    EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the interactions between Lys48 and Lys63-linked di-ubiquitins and a ubiquitin-interacting motif of S5a.
    Haririnia A; D'Onofrio M; Fushman D
    J Mol Biol; 2007 May; 368(3):753-66. PubMed ID: 17368669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
    Wang H; Jia N; Fei E; Wang Z; Liu C; Zhang T; Fan J; Wu M; Chen L; Nukina N; Zhou J; Wang G
    J Neurochem; 2007 Jun; 101(6):1651-61. PubMed ID: 17302910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
    Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
    Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasome subunit Rpn1 binds ubiquitin-like protein domains.
    Elsasser S; Gali RR; Schwickart M; Larsen CN; Leggett DS; Müller B; Feng MT; Tübing F; Dittmar GA; Finley D
    Nat Cell Biol; 2002 Sep; 4(9):725-30. PubMed ID: 12198498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
    Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
    FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
    Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
    J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of proteins that interact with mammalian peptide:N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradation.
    Park H; Suzuki T; Lennarz WJ
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11163-8. PubMed ID: 11562482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.